In the November 2007
issue:
Health Care Acquisition Premiums--
Five-Year Study Shows Upward Trend From 2004
Examination of premiums paid in health care
transactions from January 2002 through September 2007 reveals an upward
trend since 2004.
...
October’s M&A Market--
102 Deals Announced Worth $14.0 Billion
Deal volume surged to its highest monthly level ever. A total of $14.0
billion was committed to fund this robust activity.
...
Infusion Therapy Attracts Investors--
Renewed Buyer Interest Driving Valuations Up
Investor enthusiasm for infusion therapy services is increasing, with
companies acquiring providers to complement their specialty pharmacy
business lines.
...
In the Departments
Services
-Health Care Services
-Deal Summaries
-Additional Transactions
-Transaction Updates
Technology
-Health Care Technology
-Deal Summaries
-Additional Transactions
-Transaction Updates
Sign up for a trial subscription and get
the current issue!
Read more about
The Health Care M&A Monthly.
Articles Archive
Companies Mentioned in this issue:
November 2007
A
Accredo Health p9
Alere Medical p8
Almost Family p4
Amedisys p4
Amity Group p8
Anacor Pharmaceuticals p10
Apria Healthcare Group p1
Aspreva Pharmaceuticals p16
ATS Health Services p8
B
Biogen Idec p10
Borger Plains Community Hospital p4
Bracco Diagnostics p16
Braff Group p9
Bristol-Myers Squibb p9
Brookside Assisted Living p8
BUPA p8
C
Canyon Creek Development p8
Computer Sciences Corp. p15
Concentra Network Care p8
CORA Health Services p8
Coram p1
Cornerstone Health Group p4
Crdentia Corp. p8
Critical Access HealthCare p4
Critical Care Systems p9
Critical Homecare Solutions p9
Cubist Pharmaceuticals p10
CVC Asia Pacific p8
D
DaVita p9
Deaconess Enterprises p9
E
Elan Corp. p15
Eli Lilly p16
Enpath p16
Excel-Tech p16
F
Family and Children’s Services p4
First Consulting Group p15
Franciscan Missionaries of Our Lady Health System p4
G
Galapagos p10
Galenica Group p16
Genetech p15
Gentiva Specialty Pharmacy p9
GlaxoSmithKline p10
Greatbatch p16
Guardian Healthcare p8
H
Haemonetics Corp. p16
Haemoscope Corp. p16
Health Care Services Corp. p8
Highland Capital Management p4
HomeChoice Partners p9
I
Illumigen Biosciences p10
Inverness Medical Innovations p8
J
Janssen Pharmaceutica p10
Johnson & Johnson p10
K
Kirin Brewery Company p16
Kyowa Hakko Kyogo p16
L
Louisiana HomeCare p4
Louisiana HomeCare of Lafayette p4
Louisiana HomeCare of Monroe p4
M
MacroGenics p16
McKesson Corp. p9
Medco Health Solutions p9
Medical People Health Services p8
Morgan Joseph & Co. p7
N
Natus Medical p16
New American Healthcare p4
O
Oncology Therapeutics Network p9
One Equity Partners p9
OptionCare p9
Orchid Cellmark p8
Our Lady of Lourdes Regional Medical Center p4
P
Pfizer p10
Providence Service Corp. p4
Q
Quality of Life Holdings p4
Quan Emerteq p16
R
Radiation Therapy Services p4
Raytel Cardiac Services p8
Raytel Medical Corp. p8
ReliaGene Technologies p8
Royal Philips Electronics p8
S
sanofi-aventis p10
Select Medical Corp. p8
Shelby Regional Medical Center p4
SHL Telemedicine p8
St. Francis Medical Center p4
Sunwest Management p8
Synta Pharmaceutical Corp. p10
T
TA Associates p8
Tenet Healthcare Corp. p4
Texas True Choice p8
The Bracco Group p16
U
UBS Investment Bank p16
V
Vestar Capital Partners p2
Viant Holdings p8
W
Wachovia Capital Markets, LLC p8
Walgreens p9
WhiteEagle National p8
Z
Ziegler Healthcare Consulting p4
|
October’s M&A Market--
102 Deals Announced Worth $14.0 Billion
Email this
article to a friend
Email Editor
October saw a total of 102 mergers and
acquisitions announced in the 13 sectors of the health care industry, one
of the highest monthly levels ever recorded. The four sectors of the
health care technology segment accounted for a total of 64 deals, with
health care services bringing home the remaining 38. The three sectors
with the highest deal volume, Medical Devices (20), Biotechnology (19) and
Pharmaceuticals (19), when combined, accounted for 56% of all activity.
Based on prices revealed to date, nearly $14.0 billion was committed to
finance October’s M&A activity. The technology segment accounted for $11.3
billion, or 93% of the total dollar volume. Five billion-dollar deals were
announced, worth a combined total of $7.0 billion, or just half of the
month’s total amount, as compared with the first nine months of 2007
during which time billion-dollar deals accounted for 70% of total dollar
volume.
Following the uncertainties of the past few months, October’s M&A activity
may herald a major shift in the market away from the splashy
billion-dollar deals towards an increased volume of smaller transactions.
Interestingly, the median price per deal for October was $54.0 million, as
compared with the $31.5 million for the first nine months of 2007.
However, financial investors were not altogether absent from October’s
activity, and included two buyers, one of which, Vestar Capital Partners,
announced a $1.1 billion acquisition in the laboratory sector. Also, three
private equity firms were confident enough in the market to profitably
sell off some of their previous investments.
|
|
FREE TRIAL
TO THE
HEALTH CARE M&A INFORMATION SERVICE!
If you like this article, there’s lots more
waiting for you in The Healthcare M&A Information Service. It’s the
bible of what's going on in health care M&A today.
Sign up for two free months right now! There’s no
obligation, no writing “cancel” on a bill. Happy reading!
|
|
|
|
|
|
